Exploring New Opportunities in Biopharmaceutical Processes

The 8th Biopharmaceutical Process Development Conference

2025.8.7-8.8

Shanghai丨Zhangjiang Science Hall

On August 7-8, 2025, the 8th Biopharmaceutical Process Development Conference (BPD 2025) was successfully held at Zhangjiang Science Hall in Shanghai. The conference brought together over 5,000 professionals, 160+ speakers, fostering in-depth interactions and idea exchanges among industry peers to advance biopharmaceutical development and collaboration.

Innovative drugs, as the core safeguard of human health, have become a key sector for industrial upgrading, with technological innovation serving as the primary driver for the rapid development of the innovative drug sector. The application of cutting-edge technologies such as gene editing and cell therapy is propelling the biopharmaceutical industry toward personalized and precision-oriented exploration.

To align with the evolving needs of the industry and clients, Morimatsu continues to focus on novel therapies, with deep expertise in vaccines, antibodies, cells, genes, and nucleic acids. At the conference, visitors showed keen interest in the three major solutions we exhibited.

1.Upstream Culture Solutions

The Upstream Culture Solution includes glass bioreactors suitable for cell and microbial cultivation, as well as the 2D Wave single-use bioreactors featuring a unique two-dimensional motion mode, providing a one-stop platform solution from research and development to commercial production for cell therapy and related fields.

2.Single-Use Solutions

Currently, single-use systems have become indispensable in biopharmaceutical production processes. Morimatsu's single-use solution, with its advantages of speed, flexibility, and low cross-contamination risk, enables efficient and adaptable biopharmaceutical production.

3.Modular Plant Solutions

To align with the rapid development of biopharmaceutical industry and help clients swiftly respond to market changes while enhancing competitiveness, Pharmadule Morimatsu AB's modular plant solutions offer turnkey services from design to validation, significantly reducing construction time and on-site work cycles to meet the demands for rapid drug commercialization and flexible capacity expansion.

Through continuous research and development of cutting-edge technologies tailored to clients' practical needs, Morimatsu empowers clients to achieve more efficient and higher-quality production, accelerating the translation of innovative R&D outcomes into tangible results, and contributing to advancing China's biopharmaceutical globalization.

At our next exhibition, we will showcase even more refined innovative products and more attentive, professional services. We look forward to reuniting with you to jointly embark another remarkable journey.

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.